128 related articles for article (PubMed ID: 35853491)
1. Plasma Antiretinal Autoantibody Profiling and Diagnostic Efficacy in Patients With Autoimmune Retinopathy.
Bae SH; Hong HK; Lee JY; Kim MS; Lee CS; Sagong M; Kim SY; Oh BL; Yoon YH; Shin JP; Jo YJ; Joo K; Park SJ; Park KH; Woo SJ
Am J Ophthalmol; 2023 Jan; 245():145-154. PubMed ID: 35853491
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy.
Zeng HY; Liu Q; Peng XY; Cao K; Jin SS; Xu K
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1759-1764. PubMed ID: 31119427
[TBL] [Abstract][Full Text] [Related]
3. Serum antiretinal antibodies and cytokine profiling in autoimmune retinopathy and their association with clinical outcomes.
Zeng HY; Liu Q; Cao K; Wang NL; Wang Y; Zhang ZJ; Ge Q
Graefes Arch Clin Exp Ophthalmol; 2023 Sep; 261(9):2651-2660. PubMed ID: 37099128
[TBL] [Abstract][Full Text] [Related]
4. Association of Circulating Antiretinal Antibodies With Clinical Outcomes in Retinitis Pigmentosa.
Bianco L; Arrigo A; Antropoli A; Del Fabbro S; Panina-Bordignon P; Peri C; Brambilla E; Pina A; Basile G; Hassan Farah R; Saladino A; Aragona E; Cascavilla ML; Bandello F; Battaglia Parodi M; Pulido JS
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):13. PubMed ID: 38088826
[TBL] [Abstract][Full Text] [Related]
5. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Japanese Patients With Anti-α-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of Multiple Drusen.
Ando R; Saito W; Kanda A; Kase S; Fujinami K; Sugahara M; Nakamura Y; Eguchi S; Mori S; Noda K; Shinoda K; Ishida S
Am J Ophthalmol; 2018 Dec; 196():181-196. PubMed ID: 30195891
[TBL] [Abstract][Full Text] [Related]
7. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
8. Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy.
Ten Berge JC; van Rosmalen J; Vermeer J; Hellström C; Lindskog C; Nilsson P; Qundos U; Rothova A; Schreurs MW
PLoS One; 2016; 11(12):e0167909. PubMed ID: 27930731
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune Retinopathy: An Immunologic Cellular-Driven Disorder.
Heckenlively JR; Lundy SK
Adv Exp Med Biol; 2018; 1074():193-201. PubMed ID: 29721944
[TBL] [Abstract][Full Text] [Related]
11. The need for standardization of antiretinal antibody detection and measurement.
Forooghian F; Macdonald IM; Heckenlively JR; Héon E; Gordon LK; Hooks JJ; Detrick B; Nussenblatt RB
Am J Ophthalmol; 2008 Oct; 146(4):489-95. PubMed ID: 18672221
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies.
Hashimoto Y; Saito W; Namba K; Mizuuchi K; Iwata D; Noda K; Kanda A; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1751-1758. PubMed ID: 31065846
[TBL] [Abstract][Full Text] [Related]
13. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.
Saito M; Saito W; Kanda A; Ohguro H; Ishida S
BMC Ophthalmol; 2014 Jan; 14():5. PubMed ID: 24428923
[TBL] [Abstract][Full Text] [Related]
14. SPATA7: Evolving phenotype from cone-rod dystrophy to retinitis pigmentosa.
Matsui R; McGuigan Iii DB; Gruzensky ML; Aleman TS; Schwartz SB; Sumaroka A; Koenekoop RK; Cideciyan AV; Jacobson SG
Ophthalmic Genet; 2016 Sep; 37(3):333-8. PubMed ID: 26854980
[TBL] [Abstract][Full Text] [Related]
15. Unilateral manifestation of autoimmune retinopathy.
Almeida DR; Chin EK; Niles P; Kardon R; Sohn EH
Can J Ophthalmol; 2014 Aug; 49(4):e85-7. PubMed ID: 25103665
[No Abstract] [Full Text] [Related]
16. Autoimmune retinopathy with positive anti-recoverin antibodies not associated with neoplasms: Case report.
Oporto Caroca JI; Oporto Caroca J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):540-544. PubMed ID: 31470998
[TBL] [Abstract][Full Text] [Related]
17. ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosa.
Nair AA; Marmor MF
Doc Ophthalmol; 2017 Jun; 134(3):175-183. PubMed ID: 28451987
[TBL] [Abstract][Full Text] [Related]
18. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status.
Hashimoto Y; Saito W; Kanaizumi S; Saito M; Noda K; Kanda A; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):2967-2976. PubMed ID: 33876277
[TBL] [Abstract][Full Text] [Related]
20. Enolase autoantibodies and retinal function in multiple sclerosis patients.
Forooghian F; Adamus G; Sproule M; Westall C; O'Connor P
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1077-84. PubMed ID: 17219105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
